| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0004 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |